BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 17408375)

  • 1. Clinical utilization of chemokines to combat cancer: the double-edged sword.
    Dell'Agnola C; Biragyn A
    Expert Rev Vaccines; 2007 Apr; 6(2):267-83. PubMed ID: 17408375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunotherapy with chemoattractant peptides.
    Coscia M; Biragyn A
    Semin Cancer Biol; 2004 Jun; 14(3):209-18. PubMed ID: 15246057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional study of cytokines and chemokines involved in tumorigenesis.
    Zeng J; Xie K; Wu H; Zhang B; Huang C
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):276-85. PubMed ID: 22221060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemokine network: a target in cancer biology?
    Slettenaar VI; Wilson JL
    Adv Drug Deliv Rev; 2006 Oct; 58(8):962-74. PubMed ID: 16996642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy.
    Vilgelm AE; Richmond A
    Front Immunol; 2019; 10():333. PubMed ID: 30873179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors.
    Argyle D; Kitamura T
    Front Immunol; 2018; 9():2629. PubMed ID: 30483271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines in cancer.
    Chow MT; Luster AD
    Cancer Immunol Res; 2014 Dec; 2(12):1125-31. PubMed ID: 25480554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization.
    Marcuzzi E; Angioni R; Molon B; Calì B
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30591657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines in tumor immunotherapy.
    Flanagan K; Kaufman HL
    Front Biosci; 2006 Jan; 11():1024-30. PubMed ID: 16146794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.
    Nagarsheth N; Wicha MS; Zou W
    Nat Rev Immunol; 2017 Sep; 17(9):559-572. PubMed ID: 28555670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine-chemokine receptors in cancer immunotherapy.
    Stewart TJ; Smyth MJ
    Immunotherapy; 2009 Jan; 1(1):109-27. PubMed ID: 20635978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key role of chemokines and chemokine receptors in inflammation, immunity, neoplasia, and infectious disease.
    Rottman JB
    Vet Pathol; 1999 Sep; 36(5):357-67. PubMed ID: 10490203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine-based immunotherapy: delivery systems and combination therapies.
    Mohit E; Rafati S
    Immunotherapy; 2012 Aug; 4(8):807-40. PubMed ID: 22947009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine biology in cancer.
    Balkwill F
    Semin Immunol; 2003 Feb; 15(1):49-55. PubMed ID: 12495640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines.
    Mocellin S; Nitti D
    Med Res Rev; 2008 May; 28(3):413-44. PubMed ID: 17694549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cell recruitment and cell-based system for cancer therapy.
    Gao JQ; Okada N; Mayumi T; Nakagawa S
    Pharm Res; 2008 Apr; 25(4):752-68. PubMed ID: 17891483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and prospects of immunotherapy as cancer treatment.
    Rescigno M; Avogadri F; Curigliano G
    Biochim Biophys Acta; 2007 Sep; 1776(1):108-23. PubMed ID: 17720322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of chemokines in cancer immune surveillance by the adaptive immune system.
    Krieg C; Boyman O
    Semin Cancer Biol; 2009 Apr; 19(2):76-83. PubMed ID: 19038343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major fundamental factors hindering immune system in defense against tumor cells: The link between insufficiency of innate immune responses, metabolism, and neurotransmitters with effector immune cells disability.
    Bahrambeigi S; Sanajou D; Shafiei-Irannejad V
    Immunol Lett; 2019 Aug; 212():81-87. PubMed ID: 31260743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.